Form4insider filings, from the source

SEC Form 4 · accession 0001061983-17-000065

CYTOKINETICS INC · CYTK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Caryn Gordon McDowell
Officer — GC & Chief Compliance Officer
Period of report
Nov 2, 2017
Accepted (ET)
Nov 6, 2017 · 8:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockNov 2, 2017M77$6.67A17,982D
Common StockNov 2, 2017S2,460$12.90D15,522D
Common StockNov 2, 2017M653$6.67A16,175D
Common StockNov 2, 2017S1,800$13.00D14,375D
Common StockNov 2, 2017M625$6.37A15,000D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Incentive Stock Option (right to buy)$6.37Nov 2, 2017M625DMay 29, 2016May 29, 2025Common Stock62511,875D
Incentive Stock Option (right to buy)$6.67Nov 2, 2017M653DMar 23, 2016Feb 23, 2026Common Stock65319,343D
Non-Qualified Stock Option (right to buy)$6.67Nov 2, 2017M77DMar 23, 2016Feb 23, 2026Common Stock771,075D

Explanation of responses